A. E. Egorova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
A. E. Egorova has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- A. S. Gubaeva
Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Moscow 125315, Russia
1 shared publication - Anna Arkadievna Maznina
Moscow Center for Advanced Studies, Kulakova str. 20, Moscow 123592, Russia
1 shared publication - D. A. Naumova
Federal Research Center for Original and Prospective Biomedical and Pharmaceutical Technologies, Baltiyskaya Street 8, 125315 Moscow, Russia
1 shared publication - Dmitry Vyacheslavovich Tabakov
Federal State Budgetary Scientific Institution “Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies”, Moscow, Russia
1 shared publication - Ekaterina A. Astakhova
Laboratory of Immunochemistry, National Research Center Institute of Immunology, Federal Medical Biological Agency of Russia, 115522 Moscow, Russia
1 shared publication - Irina G. Rybkina
Morozovskaya Children’s City Clinical Hospital, 4 Dobryninskiy Pereulok, 1/9, 119049 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 19 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5911
Spectral Flow Cytometry: The Current State and Future of the Technology
Flow cytometry is a powerful and widely used tool for the analysis of various cell populations, but its capabilities are severely limited by the need to apply correction of fluorescent signals from near or similar fluorochromes when analyzing multicolor panels. Spectral flow cytometry extends the capabilities of classical cytometry by reading the full fluorescence spectrum of fluorophores and their subsequent spectral separation. This significantly increases the number of markers analyzed in a single panel and thus allows for more in-depth studies of cell populations. In the age of big data analysis, this represents a serious advantage of spectral cytometry and can significantly increase its use in scientific and clinical practice. This review describes the principle of spectral cytometry, advantages and limitations of the method, and summarizes the newest deep immunophenotyping panels developed and validated for spectral cytometry.
- 19 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5911
Open AccessSpectral Flow Cytometry: The Current State and Future of the Technology
Flow cytometry is a powerful and widely used tool for the analysis of various cell populations, but its capabilities are severely limited by the need to apply correction of fluorescent signals from near or similar fluorochromes when analyzing multicolor panels. Spectral flow cytometry extends the capabilities of classical cytometry by reading the full fluorescence spectrum of fluorophores and their subsequent spectral separation. This significantly increases the number of markers analyzed in a single panel and thus allows for more in-depth studies of cell populations. In the age of big data analysis, this represents a serious advantage of spectral cytometry and can significantly increase its use in scientific and clinical practice. This review describes the principle of spectral cytometry, advantages and limitations of the method, and summarizes the newest deep immunophenotyping panels developed and validated for spectral cytometry.